Verheij M - Search Results

1

Genetic Factors Associated with a Poor Outcome in Head and Neck Cancer Patients Receiving Definitive Chemoradiotherapy.

Vossen DM, Verhagen CVM, van der Heijden M, Essers PBM, Bartelink H, Verheij M, Wessels LFA, van den Brekel MWM, Vens C. Vossen DM, et al. Among authors: verheij m. Cancers (Basel). 2019 Mar 29;11(4):445. doi: 10.3390/cancers11040445. Cancers (Basel). 2019. PMID: 30934880 Free PMC article.

2

Radiation-induced apoptosis--the ceramide-SAPK signaling pathway and clinical aspects.

Verheij M, van Blitterswijk WJ, Bartelink H. Verheij M, et al. Acta Oncol. 1998;37(6):575-81. doi: 10.1080/028418698430287. Acta Oncol. 1998. PMID: 9860316

3

Towards prediction and modulation of treatment response.

Bartelink H, Begg A, Martin JC, van Dijk M, van 't Veer L, van der Vaart P, Verheij M. Bartelink H, et al. Among authors: verheij m. Radiother Oncol. 1999 Jan;50(1):1-11. doi: 10.1016/s0167-8140(99)00009-2. Radiother Oncol. 1999. PMID: 10225551 Review.

4

Translational research offers individually tailored treatments for cancer patients.

Bartelink H, Begg AC, Martin JC, van Dijk M, Moonen L, van 't Veer LJ, Van de Vaart P, Verheij M. Bartelink H, et al. Among authors: verheij m. Cancer J Sci Am. 2000 Jan-Feb;6(1):2-10. Cancer J Sci Am. 2000. PMID: 10696731 Review.

5

Radiation-induced apoptosis.

Verheij M, Bartelink H. Verheij M, et al. Cell Tissue Res. 2000 Jul;301(1):133-42. doi: 10.1007/s004410000188. Cell Tissue Res. 2000. PMID: 10928286 Review.

6

Concurrent chemotherapy and radiation for locally advanced squamous cell cancers: what is the schedule of choice?

Schornagel JH, Verheij M, Bartelink H. Schornagel JH, et al. Among authors: verheij m. Curr Oncol Rep. 2001 Jan;3(1):1-2. doi: 10.1007/s11912-001-0034-3. Curr Oncol Rep. 2001. PMID: 11123863 No abstract available.

7

Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder.

Moonen L, Ong F, Gallee M, Verheij M, Horenblas S, Hart AA, Bartelink H. Moonen L, et al. Among authors: verheij m. Int J Radiat Oncol Biol Phys. 2001 Apr 1;49(5):1305-10. doi: 10.1016/s0360-3016(00)01503-0. Int J Radiat Oncol Biol Phys. 2001. PMID: 11286838

8

Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53.

Ong F, Moonen LM, Gallee MP, ten Bosch C, Zerp SF, Hart AA, Bartelink H, Verheij M. Ong F, et al. Among authors: verheij m. Radiother Oncol. 2001 Nov;61(2):169-75. doi: 10.1016/s0167-8140(01)00421-2. Radiother Oncol. 2001. PMID: 11690683

9

The combined use of radiotherapy and chemotherapy in the treatment of solid tumours.

Bartelink H, Schellens JH, Verheij M. Bartelink H, et al. Among authors: verheij m. Eur J Cancer. 2002 Jan;38(2):216-22. doi: 10.1016/s0959-8049(01)00363-x. Eur J Cancer. 2002. PMID: 11803138 Review.

10

[The concomitant use of radiotherapy and chemotherapy for the treatment of solid malignant tumors].

Bartelink H, Schellens JH, Verheij M. Bartelink H, et al. Among authors: verheij m. Ned Tijdschr Geneeskd. 2002 Mar 16;146(11):504-8. Ned Tijdschr Geneeskd. 2002. PMID: 11925799 Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

318 results

Search Page

Filters